Navigation Links
Mayo Clinic: Obese patients with HER2-positive breast cancer may have worse outcomes
Date:12/8/2011

obese patients, and found that patients fared best in Arm C. In this arm, the difference between BMI and outcome was not statistically significant, Dr. Crozier says. Herceptin was powerful enough to provide an equal benefit in patients with vastly varying body weights, she says.

"We are continually searching for approaches that will help our patients have the best outcome possible after their diagnosis of breast cancer, and this study suggests that excess body weight may make a difference," says senior investigator Edith Perez, M.D., director of Mayo Clinic's breast program in Florida.


'/>"/>

Contact: Joe Dangor
dangor.yusuf@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mayo Clinic: Young women with rheumatoid arthritis at more risk for broken bones
2. Mayo Clinic: Short training course significantly improves detection of precancerous polyps
3. Mayo Clinic: Primary physicians may hold key to suicide prevention
4. Mayo Clinic: Flaxseed no cure for hot flashes during breast cancer or menopause
5. Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award
6. Atlanta School of Massage Celebrates 30th Anniversary with a New Green Design and New Name for its Teaching Clinic: SensAbility
7. Vitamin D Levels Tied to Diabetes Risk in Obese Kids
8. Colon Cancer Prognosis Worse for the Obese, Type 2 Diabetics
9. Low-Cal Diet Cuts Fat Around Heart in Obese People: Study
10. Outlook Good for Obese Kids Who Lose Weight
11. Primary care-based weight intervention helps obese patients reduce weight
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... New York, New York (PRWEB) March 04, 2015 ... ( http://www.lipitorlawsuitcenter.com/ ) that allege the statin drug caused ... forward in the U.S. District Court, District of South ... Conference will be convened on March 26, 2015 at ... have been directed to submit a Joint Status report ...
(Date:3/4/2015)... Smokers across America are the target of ... Smokers' from Aqua-Tine, the new brand that helps you ... to establish a clear point of view for your ... Love Smokers' elevates the Aqua-Tine brand, gives it an ... bold tone of voice that is also genuinely thoughtful ...
(Date:3/4/2015)... 2015 Vancouver chiropractic clinic, Backs ... awards in the prestigious Vancouver Courier “Stars of ... 2015. The company secured third place in the ... “Best Registered Massage Therapist” category. , As ... Canada, The Vancouver Courier is a semiweekly local ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 As ... Endometriosis can be a painful condition in ... spreading outside of the uterus leading to very unpleasant ... families. Endometriosis can have a terrible effect on women’s ... is also the most common cause of infertility in ...
(Date:3/4/2015)... Dallas, Texas (PRWEB) March 04, 2015 ... materials, equipment, downstream client survey, marketing channels, industry ... basic overview of the industry, including spices definitions, ... and Chinese domestic market analysis are provided with ... landscape of the market. A comparison between the ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:Backs in Action Receives Two Awards in The Vancouver Courier Readers’ Choice Awards 2015 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3
... could be a new way to help prevent heart disease. ... high-density lipoprotein levels, also known as good cholesterol. Statins have ... disease. They are commonly used to lower low-density lipoprotein (LDL) ... a low level of good cholesterol. In fact, a low ...
... examine the initial mammogram immediately so any follow-up tests ... Between 5 percent and 11 percent of all screening ... for a follow-up mammogram. Many abnormal mammograms turn out ... a breast cancer diagnosis within one year. Even when ...
... examine whether current procedures to treat sore throats were ... an estimated 6.7 million annual sore throat patients, 70 ... of throat cultures and rapid tests to detect streptococcus ... medical help for their sore throats. ,After sampling ...
... performing CPR on heart attack victims found they regularly ... by American Heart Association CPR standards.While the standards call ... personnel were delivering on average 37 -- essentially causing ... to follow the guidelines, they gave about 22 breaths ...
... show attention deficit/hyperactivity disorder (ADHD) affects up to 12 percent ... that increased attention problems at age 7 among kids was ... and toddlers.The study tracked the number of hours kids watched ... about two hours of television a day. Three-year-olds watched about ...
... fast track to heart disease, say researchers based on recent ... risk can be significantly reduced. ,Researchers used two noninvasive ... that leads to heart attacks and stroke -- in the ... had not yet entered puberty, their test results were similar ...
Cached Medicine News:
(Date:3/4/2015)... China Biologic Products, Inc. (NASDAQ: CBPO, "China ... biopharmaceutical company in China, today announced its financial results ... Fourth Quarter 2014 Financial Highlights ... increased by 36.2%, or 36.8% excluding the impact of ... $42.6 million in the same quarter of 2013. ...
(Date:3/4/2015)... PARK, Calif. , March 4, 2015 ... company in the emerging field of regenerative medicine, today ... Executive Officer, will ring The Opening Bell ® ... March 5, 2015. Asterias began trading as an NYSE ... "New York Stock Exchange is a trusted partner ...
(Date:3/4/2015)... Calif. , March 4, 2015  Nevro Corp. ... that has developed and commercialized an innovative, evidence-based neuromodulation ... that it will release financial results for the fourth ... on Wednesday, March 18, 2015. Company management will host ... (4:30 p.m. Eastern Time) on Wednesday, March 18, 2015. ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 2China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 3China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 4China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 5China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 6China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 7China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 8China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 9China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 10China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 11China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 12China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 13China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 14China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 15China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 16China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 17China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 18China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 19China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 20China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 21China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2014 22Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3
... Incorporated (Nasdaq: VPHM ) today announced data ... esterase inhibitor [human]) at the 2011 American Academy of ... through 22, in San Francisco, CA.   ... esterase inhibitor therapy indicated for routine prophylaxis against angioedema ...
... Mass., March 22, 2011 Pervasis Therapeutics, Inc. ... related to PVS-30200, the company,s investigational cell therapy ... late-breaking oral presentation at the upcoming American Association ... in Orlando, Florida. PVS-30200, which ...
Cached Medicine Technology:Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting 2Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting 3Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting 4Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting 5Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting 6Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting 2Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting 3Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting 4
10 L, Bulk Recommended for 2, 5 and 10 L pipettes....
This 10 L tip was designed for the Pipetman P-2 and P-10. Its MicroPoint design and 2 L reference mark make it ideal for low volume pipetting....
1000 L, Bulk Recommended for 500 and 1000 L pipettes....
... its wide orifice tip, the Finntip Wide ... suspensions and macromolecules like genomic DNA. This ... cell fragmentation. It is excellent for use ... model, the inside diameter of the orifice ...
Medicine Products: